{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:34:49Z","timestamp":1791023689979,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.jbspin.2010.02.004","type":"journal-article","created":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T03:32:18Z","timestamp":1271043138000},"page":"222-228","source":"Crossref","is-referenced-by-count":44,"title":["New treatment targets in osteoporosis"],"prefix":"10.1016","volume":"77","author":[{"given":"Sophie","family":"Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2010.02.004_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","article-title":"Osteoclasts: what do they do and how do they do it?","volume":"170","author":"Teitelbaum","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jbspin.2010.02.004_bib2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1126\/science.2528207","article-title":"Osteoclastic bone resorption by a polarized vacuolar proton pump","volume":"245","author":"Blair","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jbspin.2010.02.004_bib3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1359\/jbmr.1997.12.5.753","article-title":"Characterization and cellular distribution of the osteoclast ruffled membrane vacuolar H+-ATPase B-subunit using isoform-specific antibodies","volume":"12","author":"Mattsson","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib4","first-page":"633","article-title":"Molecular mechanisms of bone resorption: therapeutic implications","volume":"63","author":"Baron","year":"1996","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1016\/j.jbspin.2010.02.004_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11914-007-0005-1","article-title":"Novel osteoclast signaling mechanisms","volume":"5","author":"Shinohara","year":"2007","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jbspin.2010.02.004_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","article-title":"The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption","volume":"15","author":"Hofbauer","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib7","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI28551","article-title":"Regulation of bone mass by Wnt signaling","volume":"116","author":"Krishnan","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2010.02.004_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0105-2896.2005.00334.x","article-title":"The role of the immune system in the pathophysiology of osteoporosis","volume":"208","author":"Clowes","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jbspin.2010.02.004_bib9","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jbmr.5650110802","article-title":"Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis","volume":"11","author":"Pacifici","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2010.02.004_bib11","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/en.140.9.4367","article-title":"Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbspin.2010.02.004_bib12","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.130200197","article-title":"Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression","volume":"97","author":"Shevde","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2010.02.004_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/er.23.3.279","article-title":"Sex steroids and the construction and conservation of the adult skeleton","volume":"23","author":"Riggs","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jbspin.2010.02.004_bib14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib15","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2007-2814","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women","volume":"93","author":"Bone","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2010.02.004_bib16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2010.02.004_bib17","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1359\/jbmr.070809","article-title":"Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD","volume":"22","author":"Lewiecki","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2010.02.004_bib19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","article-title":"Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial","volume":"43","author":"Miller","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2010.02.004_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1359\/jbmr.0809010","article-title":"Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial","volume":"24","author":"Brown","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib21","article-title":"Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women Transitioning from Alendronate Therapy","author":"Kendler","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sj.clpt.6100450","article-title":"Cathepsin K inhibitors: a novel target for osteoporosis therapy","volume":"83","author":"Stoch","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jbspin.2010.02.004_bib23","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1359\/jbmr.1999.14.11.1902","article-title":"Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation","volume":"14","author":"Nishi","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib24","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1210\/jc.2003-031055","article-title":"Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis","volume":"89","author":"Fratzl-Zelman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2010.02.004_bib25","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1073\/pnas.95.23.13453","article-title":"Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice","volume":"95","author":"Saftig","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2010.02.004_bib26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.bmcl.2007.12.047","article-title":"The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K","volume":"18","author":"Gauthier","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jbspin.2010.02.004_bib27","doi-asserted-by":"crossref","DOI":"10.1359\/jbmr.091035","article-title":"Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density","author":"Bone","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0955-0674(00)00251-9","article-title":"Anoikis mechanisms","volume":"13","author":"Frisch","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jbspin.2010.02.004_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/me.2004-0161","article-title":"Unoccupied alpha(v)beta3 integrin regulates osteoclast apoptosis by transmitting a positive death signal","volume":"19","author":"Zhao","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jbspin.2010.02.004_bib30","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1172\/JCI119404","article-title":"A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo","volume":"99","author":"Engleman","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2010.02.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcb.240590102","article-title":"Molecular mechanisms of bone resorption","volume":"59","author":"Teitelbaum","year":"1995","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jbspin.2010.02.004_bib32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/1097-4644(20010501)81:2<320::AID-JCB1047>3.0.CO;2-M","article-title":"Cloning and characterization of the murine beta(3) integrin gene promoter: identification of an interleukin-4 responsive element and regulation by STAT-6","volume":"81","author":"McHugh","year":"2001","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jbspin.2010.02.004_bib33","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1210\/jc.2004-2126","article-title":"Effect of L-000845704, an alphaVbeta3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women","volume":"90","author":"Murphy","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2010.02.004_bib34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bone.2006.09.025","article-title":"Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women","volume":"40","author":"Henriksen","year":"2007","journal-title":"Bone"},{"issue":"Suppl. 1","key":"10.1016\/j.jbspin.2010.02.004_bib35","first-page":"S 37","article-title":"GLP-2 significantly increases hip BMD in postmenopausal women: A 120-day study [abstract]","volume":"22","author":"Henriksen","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib36","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","article-title":"Targeted disruption of the c-src protooncogene leads to osteopetrosis in mice","volume":"64","author":"Soriano","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jbspin.2010.02.004_bib37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bone.2003.06.004","article-title":"Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1\/2 pathway","volume":"34","author":"Recchia","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2010.02.004_bib38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1196\/annals.1346.042","article-title":"Future anti-catabolic therapeutic targets in bone disease","volume":"1068","author":"Boyce","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jbspin.2010.02.004_bib39","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1083\/jcb.111.3.1305","article-title":"Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts","volume":"111","author":"Vaananen","year":"1990","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jbspin.2010.02.004_bib40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/77131","article-title":"Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis","volume":"25","author":"Frattini","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.jbspin.2010.02.004_bib41","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1210\/jc.2005-2017","article-title":"Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II","volume":"91","author":"Kornak","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2010.02.004_bib42","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1359\/JBMR.040302","article-title":"The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation","volume":"19","author":"Schaller","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-4020-6191-2_6","article-title":"The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics","volume":"45","author":"Brown","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.jbspin.2010.02.004_bib44","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.jbspin.2010.02.004_bib45","first-page":"S50","article-title":"Ronacaleret, a novel calcium-sensing receptor antagonist, demonstrates potential as an oral bone forming therapy in healthy postmenopausal women [abstract]","volume":"23","author":"Fitzpatrick","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib46","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2010.02.004_bib47","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.jbspin.2010.02.004_bib48","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib49","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"Suppl. 1","key":"10.1016\/j.jbspin.2010.02.004_bib50","first-page":"S37","article-title":"Anti-sclerostin antibody increases markers of bone formation in healthy postmenopausal women [abstract]","volume":"22","author":"Padhi","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib51","doi-asserted-by":"crossref","first-page":"21427","DOI":"10.1074\/jbc.M800014200","article-title":"DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation","volume":"283","author":"Semenov","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2010.02.004_bib52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bone.2007.05.009","article-title":"Bone mass is inversely proportional to Dkk1 levels in mice","volume":"41","author":"MacDonald","year":"2007","journal-title":"Bone"},{"issue":"Suppl. 1","key":"10.1016\/j.jbspin.2010.02.004_bib53","first-page":"S60","article-title":"Fully human anti-DKK1 antibodies increase bone formation and resolve osteopenia in mouse models of estrogen-deficiency induced bone loss [abstract]","volume":"23","author":"Glantschnig","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib54","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1074\/jbc.M801681200","article-title":"Constitutively Activated ALK2 and Increased SMAD1\/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva","volume":"284","author":"Fukuda","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2010.02.004_bib55","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1073\/pnas.0711263105","article-title":"A soluble activin type IIA receptor induces bone formation and improves skeletal integrity","volume":"105","author":"Pearsall","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2010.02.004_bib56","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1359\/jbmr.081208","article-title":"Single-dose, randomized, double-blind, placebo controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women","volume":"24","author":"Ruckle","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2010.02.004_bib57","doi-asserted-by":"crossref","unstructured":"Fajardo RJ, Manoharan RK, Pearsall RS, et al. Treatment with a soluble receptor for activin improves bone mass and structure in the axial and appendicular skeleton of female cynomolgus macaques (Macaca fascicularis). Bone 2010;46:64\u201371.","DOI":"10.1016\/j.bone.2009.09.018"},{"key":"10.1016\/j.jbspin.2010.02.004_bib58","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","article-title":"T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jbspin.2010.02.004_bib59","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1074\/jbc.M104957200","article-title":"Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling","volume":"277","author":"Wei","year":"2002","journal-title":"J Biol Chem"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10000217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10000217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T01:16:55Z","timestamp":1559006215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X10000217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S1297319X10000217"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2010.02.004","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}